ABIDE THERAPEUTICS INC has a total of 167 patent applications. It decreased the IP activity by 57.0%. Its first patent ever was published in 2013. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are IKERCHEM S L, CERMOL SA and VIA PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 23 | |
#2 | United States | 18 | |
#3 | China | 13 | |
#4 | Canada | 11 | |
#5 | Brazil | 8 | |
#6 | Republic of Korea | 8 | |
#7 | Chile | 7 | |
#8 | Colombia | 7 | |
#9 | Israel | 7 | |
#10 | Argentina | 6 | |
#11 | Ecuador | 6 | |
#12 | EPO (European Patent Office) | 6 | |
#13 | Nicaragua | 6 | |
#14 | Peru | 6 | |
#15 | Taiwan | 6 | |
#16 | Costa Rica | 5 | |
#17 | Mexico | 5 | |
#18 | Philippines | 5 | |
#19 | South Africa | 4 | |
#20 | Japan | 3 | |
#21 | Australia | 2 | |
#22 | Singapore | 2 | |
#23 | EAPO (Eurasian Patent Organization) | 1 | |
#24 | Hong Kong | 1 | |
#25 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Medical technology | |
#5 | Foods and drinks |
# | Name | Total Patents |
---|---|---|
#1 | Grice Cheryl A | 135 |
#2 | Jones Todd K | 62 |
#3 | Cisar Justin S | 52 |
#4 | Buzard Daniel J | 50 |
#5 | Weber Olivia D | 43 |
#6 | Shaghafi Michael B | 39 |
#7 | White Nicole S | 23 |
#8 | Cheryl A Grice | 22 |
#9 | Duncan Katharine K | 22 |
#10 | Chang Jae Won | 21 |
Publication | Filing date | Title |
---|---|---|
CN110709084A | Dual MAGL and FAAH inhibitors | |
CA3043610A1 | Crystalline forms of a magl inhibitor | |
AR110088A1 | MAGL INHIBITORS | |
CR20190241A | Magl inhibitors | |
CN109996790A | Piperazine carbamate and its preparation and application | |
CN109496213A | Spiro-compound and its preparation and application | |
WO2017087863A1 | Pyrazole compounds and methods of making and using same | |
WO2017087858A1 | Pyrazole compounds and methods of making and using same | |
US2018282288A1 | Lp-PLA2 inhibitors | |
KR20180004263A | Treatment of inflammation or neuropathic pain | |
WO2016149401A2 | Piperazine carbamates and methods of making and using same | |
WO2015179563A2 | N-hydroxy bicyclic hydantoin carbamates as tools for identification of serine hydrolase targets | |
WO2015179559A2 | Pyrazole compounds and methods of making and using same | |
MX2015017961A | Pyrrolo-pyrrole carbamate and related organic compounds, pharmaceutical compositions, and medical uses thereof. | |
US2015080364A1 | Carbamate compounds and of making and using same | |
KR20140117486A | Carbamate compounds and of making and using same |